Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (953)	12/11/2000 9:07:32 AM
From: nigel bates	Respond to of 3158

Bearing in mind the realtive valuations in the sector, I'd be surprised if we don't see quite a few more of this type of deal... nig

To: Biomaven who wrote (953)	12/12/2000 6:25:27 AM
From: nigel bates	Read Replies (1) \| Respond to of 3158

Quotes from Shire's Rolf Stahel (re BCHE) - "This is a company lead by scientists. They are not qualified business people. Not enough analysts know about them, and the forecasts are all over the place. but I knew about them - I wanted this company and I got it.... We were in competition with three or four other companies. If we hadn't paid this price, we wouldn't have got it..." Leaving aside the question of just what a qualified business person might be, could the used biotech market be hotting up? nig